Hardy Reed LLC Bio Techne Corp Transaction History

Hardy Reed LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$314.62 - $411.0 $247,920 - $323,868	-788 Closed	0 $0
Q4 2020 Jan 25, 2021	SELL	$246.9 - $321.87 $56,787 - $74,030	-230 Reduced 22.59%	788 $250,000
Q2 2020 Jul 20, 2020	BUY	$185.43 - $279.56 $188,767 - $284,592	1,018 New	1,018 $269,000
Q1 2020 May 01, 2020	SELL	$161.17 - $221.51 $164,071 - $225,497	-1,018 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$189.68 - $222.09 $193,094 - $226,087	1,018 New	1,018 $223,000
Q3 2019 Oct 10, 2019	SELL	$183.56 - $216.72 $186,864 - $220,620	-1,018 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$136.09 - $200.44 $138,539 - $204,047	1,018 New	1,018 $202,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Hardy Reed LLC, based on Form 13F filings with the SEC.

Stay updated on Hardy Reed LLC with notifications on news.